Scinai Immunotherapeutics

SCNINasdaq Israel Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$1.230 M

$0.25 -5.22%

Close of 7 Aug 2026

Revenue

$1.31M

#3480 by revenue

Earnings

-$8.31M

Loss-making

Shares outstanding

13,872,899,584

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#156BiomXPHGE$4.25M
#157Calidi BiotherapeuticsCLDI$3.96M
#158Silexion TherapeuticsSLXN$1.99M
#159Scinai ImmunotherapeuticsSCNI$1.23M
#160Black TitanBTTC$1.06M

Where these numbers come from

Share counts and financials for Scinai Immunotherapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.